摘要 |
<p>There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression. More particularly, there is described an abuse resistant pharmaceutical composition for the treatment of, inter alia, depression and controlled release pharmaceutical compositions of related thereto.</p> |
申请人 |
E-THERAPEUTICS PLC;YOUNG, MALCOLM, PHILIP;IDOWU, OLUSOLA, CLEMENT;MCKEOWN, PHILIP |
发明人 |
YOUNG, MALCOLM, PHILIP;IDOWU, OLUSOLA, CLEMENT;MCKEOWN, PHILIP |